ENVB
Enveric Biosciences Inc
NASDAQ: ENVB · HEALTHCARE · BIOTECHNOLOGY
$3.95
-23.45% today
Updated 2026-04-30
Market cap
$10.01M
P/E ratio
—
P/S ratio
0.08x
EPS (TTM)
$-36.24
Dividend yield
—
52W range
$2 – $18
Volume
5.0M
Enveric Biosciences Inc (ENVB) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-304.00%
ROA
-134.10%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $333201.00 | $-352626.00 | 99.73% | -106.10% | -105.83% |
| 2007 | $750706.00 | $807276.00 | 91.57% | 33.80% | 107.54% |
| 2008 | — | $-143636.00 | — | — | — |
| 2009 | — | $-58544.00 | — | — | — |
| 2010 | — | $-39441.00 | — | — | — |
| 2011 | — | $-33380.00 | — | — | — |
| 2012 | — | $-24621.00 | — | — | — |
| 2013 | — | $-161.00 | — | — | — |
| 2014 | — | $-33644.00 | — | — | — |
| 2015 | $15.98M | $-1.89M | 36.00% | -11.71% | -11.83% |
| 2016 | $36.15M | $-2.78M | 18.08% | -14.88% | -7.69% |
| 2017 | $48.59M | $-9.07M | 21.07% | -24.63% | -18.67% |
| 2018 | $43.00M | $-16.90M | 20.89% | -16.62% | -39.30% |
| 2019 | $39.91M | $-5.60M | 20.42% | -15.85% | -14.04% |
| 2020 | $39.91M | $-6.86M | -0.30% | -14.07% | -17.20% |
| 2021 | $0.00 | $-48.98M | — | — | — |
| 2022 | $0.00 | $-18.50M | — | — | — |
| 2023 | $0.00 | $-17291.00 | — | — | — |
| 2024 | $0.00 | $-9.57M | — | — | — |
| 2025 | $0.00 | $-12.13M | — | — | — |